Suchergebnisse - (Person:"Jimenez-Fonseca, Paula")

PubPharm (7)

1

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2023

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

2

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

3

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

4

The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Borbath, I. | Garcia-Carbonero, R. | Bikmukhametov, D. | +11

5

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

6

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

7

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

1
[1]